Literature DB >> 11850344

Screening for lung cancer with low-dose spiral computed tomography.

Stephen J Swensen1, James R Jett, Jeff A Sloan, David E Midthun, Thomas E Hartman, Anne-Marie Sykes, Gregory L Aughenbaugh, Frank E Zink, Shauna L Hillman, Gayle R Noetzel, Randolph S Marks, Amy C Clayton, Peter C Pairolero.   

Abstract

Studies suggest that screening with spiral computed tomography can detect lung cancers at a smaller size and earlier stage than chest radiography can. To evaluate low-radiation-dose spiral computed tomography and sputum cytology in screening for lung cancer, we enrolled 1,520 individuals aged 50 yr or older who had smoked 20 pack-years or more in a prospective cohort study. One year after baseline scanning, 2,244 uncalcified lung nodules were identified in 1,000 participants (66%). Twenty-five cases of lung cancer were diagnosed (22 prevalence, 3 incidence). Computed tomography alone detected 23 cases; sputum cytology alone detected 2 cases. Cell types were: squamous cell, 6; adenocarcinoma or bronchioalveolar, 15; large cell, 1; small cell, 3. Twenty-two patients underwent curative surgical resection. Seven benign nodules were resected. The mean size of the non-small cell cancers detected by computed tomography was 17 mm (median, 13 mm). The postsurgical stage was IA, 13; IB, 1; IIA, 5; IIB, 1; IIIA, 2; limited, 3. Twelve (57%) of the 21 non-small cell cancers detected by computed tomography were stage IA at diagnosis. Computed tomography can detect early-stage lung cancers. The rate of benign nodule detection is high.

Entities:  

Mesh:

Year:  2002        PMID: 11850344     DOI: 10.1164/ajrccm.165.4.2107006

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  138 in total

Review 1.  Genetic testing for lung cancer risk: if physicians can do it, should they?

Authors:  Theodore W Marcy; Michael Stefanek; Kimberly M Thompson
Journal:  J Gen Intern Med       Date:  2002-12       Impact factor: 5.128

Review 2.  The lung cancer paradox: time for action.

Authors:  R C Rintoul; T Sethi
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

3.  Computer-assisted detection of pulmonary nodules: performance evaluation of an expert knowledge-based detection system in consensus reading with experienced and inexperienced chest radiologists.

Authors:  Katharina Marten; Tobias Seyfarth; Florian Auer; Edzard Wiener; Andreas Grillhösl; Silvia Obenauer; Ernst J Rummeny; Christoph Engelke
Journal:  Eur Radiol       Date:  2004-07-03       Impact factor: 5.315

4.  Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility.

Authors:  Dag Wormanns; Gerhard Kohl; Ernst Klotz; Anke Marheine; Florian Beyer; Walter Heindel; Stefan Diederich
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

5.  Detection of noncalcified pulmonary nodules on low-dose MDCT: comparison of the sensitivity of two CAD systems by using a double reference standard.

Authors:  A R Larici; M Amato; P Ordóñez; F Maggi; L Menchini; A Caulo; L Calandriello; G Vallati; S Giunta; M Crecco; L Bonomo
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

6.  The National Lung Screening Trial: overview and study design.

Authors:  Denise R Aberle; Christine D Berg; William C Black; Timothy R Church; Richard M Fagerstrom; Barbara Galen; Ilana F Gareen; Constantine Gatsonis; Jonathan Goldin; John K Gohagan; Bruce Hillman; Carl Jaffe; Barnett S Kramer; David Lynch; Pamela M Marcus; Mitchell Schnall; Daniel C Sullivan; Dorothy Sullivan; Carl J Zylak
Journal:  Radiology       Date:  2010-11-02       Impact factor: 11.105

7.  Evaluation of a method of computer-aided detection (CAD) of pulmonary nodules with computed tomography.

Authors:  G Foti; N Faccioli; M D'Onofrio; A Contro; T Milazzo; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2010-06-23       Impact factor: 3.469

8.  A Combination of Shape and Texture Features for Classification of Pulmonary Nodules in Lung CT Images.

Authors:  Ashis Kumar Dhara; Sudipta Mukhopadhyay; Anirvan Dutta; Mandeep Garg; Niranjan Khandelwal
Journal:  J Digit Imaging       Date:  2016-08       Impact factor: 4.056

Review 9.  Unleashing the power of proteomics to develop blood-based cancer markers.

Authors:  Ayumu Taguchi; Samir M Hanash
Journal:  Clin Chem       Date:  2012-10-24       Impact factor: 8.327

Review 10.  Lung cancer screening.

Authors:  Antonio Gutierrez; Robert Suh; Fereidoun Abtin; Scott Genshaft; Kathleen Brown
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.